참고문헌
- Akgul H, Tez M, Unal AE, et al (2003). Echinococcus against cancer: why not? Cancer, 98, 1999-2000. https://doi.org/10.1002/cncr.11752
- Alvarez Errico D, Medeiros A, Miguez M, et al (2001). O-glycosylation in Echinococcus granulosus: identification and characterization of the carcinoma-associated Tn antigen. Exp Parasitol, 98, 100-9. https://doi.org/10.1006/expr.2001.4620
- An WX, Fan YX, Liang XH, Liu H (2014). Changes in median ages at death from selected cancer types in relation to HLADRB1/DQB1. Asian Pac J Cancer Prev, 15, 4125-8. https://doi.org/10.7314/APJCP.2014.15.10.4125
- Donato R (2003). Intracellular and extracellular roles of S100 proteins. Microsc Res Tech, 60, 540-51. https://doi.org/10.1002/jemt.10296
- Ghaderi A, Yeganeh F, Kalantari T, et al (2004). Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast Cancer Res Treat, 86, 1-7. https://doi.org/10.1023/B:BREA.0000032918.89120.8e
- Ghaderi A (2011). CTLA4 gene variants in autoimmunity and cancer: a comparative review. Iran J Immunol, 8,127-49.
- Han CP, Kok LF, Wang PH, et al (2009). Scoring of p16INK4a immunohistochemistry based on independent nuclear staining alone can sufficiently distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study. Modern Pathology, 22, 797-806. https://doi.org/10.1038/modpathol.2009.31
- Hunter CA, Yu D, Gee M, et al (2001). Cutting edge: systemic inhibition of angiogenesis underlies resistance to tumors during acute toxoplasmosis. J Immunol, 166, 5878-81. https://doi.org/10.4049/jimmunol.166.10.5878
- Kalyoncu AF, Emri AS, Akhan O, et al (1989). Asagiesence koyu Beysehir Konya'da hidatik kist hastaligi prevalans calismasi. In: Baris I., Sahin A, editors. Hidatik kist hastaligi ve Turkiye'deki konumu Ankara: Turkiye Akciger Hastaliklari Vakfi Yayini, 90-8.
- Karadayi S, Arslan S, Sumer Z, et al (2013). Does hydatid disease have protective effects against lung cancer? Mol Biol Rep, 40, 4701-4. https://doi.org/10.1007/s11033-013-2565-8
- Maurer M, Loserth S, Kolb-Maurer A, et al (2002). A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics, 54: 1-8. https://doi.org/10.1007/s00251-002-0429-9
- Mezioug D, Touil-Boukoffa C (2009). Cytokine profile in human hydatidosis: Possible role in the immunosurveillance of patients infected with Echinococcus granulosus. Parasite, 16, 57. https://doi.org/10.1051/parasite/2009161057
- Minhas S, Bhalla S, Shokeen Y, et al (2014). Lack of any association of the CTLA-4 +49 G/A polymorphism with breast cancer risk in a North Indian population. Asian Pac J Cancer Prev, 15, 2035-8. https://doi.org/10.7314/APJCP.2014.15.5.2035
- Nonaka D, Chiriboga L, Rubin BP (2008). Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors. J Cutan Pathol, 35, 1014-9. https://doi.org/10.1111/j.1600-0560.2007.00953.x
- Pfister M, Gottstein B, Kretschmer R, Cerny T, Cerny A (2001). Elevated carbohydrate antigen 19-9 (CA 19-9) in patients with Echinococcus infection. Clin Chem Lab Med, 39, 527-30.
- Reiman JM, Kmieciak M, Manjili MH, Knutson KL (2007). Tumor immunoediting and immunosculpting pathways to cancer progression. Semin Cancer Biol, 17, 275-8.
- Rosenberg SA (2001). Progress in human tumour immunology and immunotherapy. Nature, 411, 380-4. https://doi.org/10.1038/35077246
- Scholzen T, Gerdes J (2000). The Ki-67 protein: from the known and the unknown. J Cell Physiol, 182, 311-22. https://doi.org/10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9
- Smyth MJ, Godfrey DI, Trapani JA (2001). A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol, 2, 293-99 https://doi.org/10.1038/86297
- Springer GF (1997). Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy. J Mol Med, 75, 594-602. https://doi.org/10.1007/s001090050144
- Sun T, Hu Z, Shen H, Lin D (2009). Genetic polymorphisms in cytotoxic T-lymphocyte antigen 4 and cancer: the dialectical nature of subtle human immune dysregulation. Cancer Res, 69, 6011-4.
- Sun T, Zhou Y, Yang M, et al (2008). Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res, 68, 7025-34. https://doi.org/10.1158/0008-5472.CAN-08-0806
- Swamy ST, Radha CA, Kathirvel M, Arun G, Subramanian S (2014). Feasibility study of deep inspiration breath-hold based volumetric modulated arc therapy for locally advanced left sided breast cancer patients. Asian Pac J Cancer Prev, 15, 9033-8. https://doi.org/10.7314/APJCP.2014.15.20.9033
- Van Knapen F (1980). Echinococcus granulosus infection and malignancy. BMJ, 281, 195-96. https://doi.org/10.1136/bmj.281.6234.195
- Wang L, Li D, Fu Z, et al (2007). Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population. BMC Cancer, 7, 173. https://doi.org/10.1186/1471-2407-7-173
- Yong WK, Heath DD, Savage T (1979). Possible antigenic similarity between pulmonary carcinoma and cysts of Echinococcus granulosus. Br Med J, 1463-4.
피인용 문헌
- Echinococcus granulosus: Cure for Cancer Revisited vol.5, pp.2296-858X, 2018, https://doi.org/10.3389/fmed.2018.00060